Institutional Ownership Trevi Therapeutics, Inc. (TRVI)
This table provides information about the institutional ownership of Trevi Therapeutics, Inc. (TRVI). We have compiled data on the 114 institutions that hold shares in the stock, with a total of 77.6 Million shares, which have been reported (via 13F filing form) to have a value of $498 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
482,815
shares
|
$3.1 Million
0.0% of portfolio
|
Q4 2024
Added 11.34%
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
325,000
shares
|
$2.09 Million
0.23% of portfolio
|
Q4 2024
New holding
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
236,144
shares
|
$1.52 Million
0.0% of portfolio
|
Q4 2024
Added 43.78%
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
221,664
shares
|
$1.42 Million
0.0% of portfolio
|
Q4 2024
Added 120.52%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
190,869
shares
|
$1.23 Million
0.0% of portfolio
|
Q4 2024
Reduced 3.83%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
180,419
shares
|
$1.16 Million
0.0% of portfolio
|
Q4 2024
Added 774.93%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Feb 14, 2025 Q4 2024 |
177,481
shares
|
$1.14 Million
0.02% of portfolio
|
Q4 2024
Reduced 4.31%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
173,063
shares
|
$1.11 Million
0.0% of portfolio
|
Q4 2024
Added 14.67%
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
156,267
shares
|
$1 Million
0.0% of portfolio
|
Q4 2024
Added 64.09%
|
|
Tejara Capital LTD
London, X0 |
Feb 10, 2025 Q4 2024 |
153,739
shares
|
$987,004
0.41% of portfolio
|
Q4 2024
Reduced 36.37%
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
135,807
shares
|
$871,880
0.0% of portfolio
|
Q4 2024
New holding
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
134,353
shares
|
$862,546
0.0% of portfolio
|
Q4 2024
Added 86.06%
|
|
Panagora Asset Management Inc
Boston, MA |
Feb 13, 2025 Q4 2024 |
120,304
shares
|
$772,351
0.0% of portfolio
|
Q4 2024
Added 383.13%
|
|
Gsa Capital Partners LLP
London, X0 |
Feb 07, 2025 Q4 2024 |
120,212
shares
|
$771,761
0.04% of portfolio
|
Q4 2024
Reduced 1.83%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
100,400
shares
|
$644,568
0.0% of portfolio
|
Q4 2024
Added 42.01%
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
100,000
shares
|
$642,000
0.0% of portfolio
|
Q4 2024
Added 100.0%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Feb 14, 2025 Q4 2024 |
96,784
shares
|
$621,353
0.0% of portfolio
|
Q4 2024
Added 187.05%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
96,350
shares
|
$618,567
0.0% of portfolio
|
Q2 2024
Added 28.73%
|
|
Raymond James & Associates
St Petersburg, FL |
Oct 18, 2024 Q3 2024 |
95,383
shares
|
$612,358
0.0% of portfolio
|
Q3 2024
Added 853.83%
|
|
Boothbay Fund Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
93,859
shares
|
$602,574
0.01% of portfolio
|
Q4 2024
New holding
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
89,309
shares
|
$573,363
0.0% of portfolio
|
Q4 2024
New holding
|
|
Oppenheimer & CO Inc
New York, NY |
Feb 04, 2025 Q4 2024 |
81,403
shares
|
$522,607
0.01% of portfolio
|
Q4 2024
Reduced 0.66%
|
|
Rhumbline Advisers
Boston, MA |
Jan 30, 2025 Q4 2024 |
79,874
shares
|
$512,791
0.0% of portfolio
|
Q4 2024
Reduced 2.56%
|
|
Pfs Partners, LLC
Mine Hill, NJ |
Jan 24, 2025 Q4 2024 |
79,000
shares
|
$507,180
0.17% of portfolio
|
Q2 2024
Reduced 20.2%
|
|
American Century Companies Inc
Kansas City, MO |
Feb 11, 2025 Q4 2024 |
78,143
shares
|
$501,678
0.0% of portfolio
|
Q4 2024
Added 44.74%
|